Thanks to new research findings and forms of medica­tion, growing success has been gained in recent years in treating cancer. This means there is an ever-in­creasing number of options available when it comes to success­fully treating tumors, reducing side-effects and im­proving patient quality of life. Read more here about the dia­gnosis and treat­ment options that are available to you in the Con­fraternität & Goldenes Kreuz Private Hospital.

Which types of cancer are treated at our hospital?

Working on an interdisciplinary basis, they clarify which of the available dia­gnostic procedures and treat­ment possi­bilities best meet a patient’s specific needs. In treating tumors of the lung, in­testines, lymph glands and other organs, our experts use the most modern medi­cations, effective and gentle surgical proce­dures, radiation therapy and inter­ventional radio­logy.

  • Breast cancer
  • Colorectal cancer
  • Leukemia
  • Lung cancer
  • Bladder cancer
  • Kidney cancer
  • Prostate cancer

Yes, I would like to be shown content from YouTube.
Change settings
Allow loading of YouTube this one time

One-to-one support – from the doctor you trust

In order to make you feel at ease in difficult circum­stances, a doctor from our expert onco­logical team is provi­ded as a main contact person who will provide support through­out the entire dura­tion of your treat­ment. This doctor will discuss your treat­ment plan with you at every step and will keep in constant contact with all those involved in your treat­ment. The doctor will ensure your personal well-being together with the dedi­cated nursing team.

The holistic route to treatment success

Acute therapy is at the heart of cancer treat­ment. It will not, however, improve your state of health on its own. Our patients there­fore receive holistic treat­ment and care: Dietary advice, physical therapy measures and psycho­logical care supple­ment the range of treat­ments available. After receiving such a life-changing dia­gnosis, patients in our hospital can count on re­ceiving holistic support that is dedi­cated equally to a patient’s physical and emo­tional needs.

Setting out on new routes – by determining personalized therapies

Every person is unique. And every person reacts in a different way to certain treat­ment methods. Molecular-genetic dia­gnostic investi­gation means that today, in certain circum­stances, it is possible to provide patients suffering from cancer with a custo­mized treat­ment recommen­dation. A method can be chosen from a selec­tion of modern cancer treat­ments such as tumor surgery, chemo-, radiation or immuno-therapy that is “tailor-made” to the needs of the indi­vidual patient and offers him or her the best thera­peutic outcome. At the same time, thera­pies can be avoided that will very probably not result in an improve­ment to a person’s state of health. The side-effects of any treat­ment are also reduced in ideal cases by the use of persona­lized therapy. Patients can also seek out a second opinion as part of their persona­lized therapy.

The route to successful treatment

By means of molecular genetic diagnostic investi­gation, a tumor profile is compiled that shows, with a high degree of precision, genetic changes in over 300 genes that, according to the current state of scientific know­ledge, play a role in tumors deve­loping

To this end, the oncologist providing treat­ment sends a sample of tissue to a certified labora­tory where this is then exa­mined by a team of specia­lists.

The results are then aligned with all available treat­ment options and ongoing clinical studies.

Detailed findings are then available after two to three weeks showing the various treat­ment options and provi­ding the doctor with the basis for deter­mining personalized patient treatment.

Do you have questions about your stay at our hospital?

Important information before, during and after your stay at Confraternität & Goldenes Kreuz Private Hospital, as well as details on fees and billing.

Our main attending doctors

Doctor's Office Center

All medical specialists for Hematology and internal oncology